The Ness Credit Card—powered by Mastercard—rolls out rich benefits and a new way to reward living healthy in its public beta NEW YORK–(BUSINESS WIRE)–Ness, the next great credit card company putting health first, today announced the public beta launch of the Ness Card issued by The Bank of Missouri and powered by Mastercard. Now available … [Read more…]
Top-tier investor syndicate led by FoundersX Ventures, with participation from all existing investors and new investors Alzheimer’s Drug Discovery Foundation (ADDF), Starbloom Capital, IAG Capital and WS Investment Company. Dr. Rick Kuntz, former Senior Vice President, Chief Medical and Scientific Officer at Medtronic, joins Cognito Board of Directors. CAMBRIDGE, Mass.–(BUSINESS WIRE)–#SeriesB—Cognito Therapeutics, a neurotechnology company … [Read more…]
Survey data show disconnect between students and parents on the need for quality mental and behavioral health care Data also show correlation between mental or behavioral health concerns and doubts about on-time graduation Data suggest increased education and communication can shift perceptions and help outcomes MINNETONKA, Minn.–(BUSINESS WIRE)–UnitedHealthcare today announced new survey findings revealing college … [Read more…]
-Collaboration will leverage NeoGenomics’ large oncology diagnostic laboratory and Massive Bio’s proven-at-scale proprietary artificial intelligence platform to accelerate drug discovery and optimize patient selection for clinical trials. FT. MYERS, Fla. & NEW YORK–(BUSINESS WIRE)–#AI–Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. (NASDAQ: … [Read more…]
Candida auris is a pathogenic disease commonly acquired in hospitals or long-term care facilities with no known vaccine currently available CDC has stated that 30-60% of people with C. auris bloodstream infections die and considers it one of the most significant infectious diseases in the world today MOUNT VERNON, N.Y.–(BUSINESS WIRE)–Applied UV, Inc. (NasdaqCM: AUVI) … [Read more…]
KANAGAWA, Japan–(BUSINESS WIRE)–#Glypican3–PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President and CEO: Patrick C. Reid, hereinafter “PeptiDream”) (Tokyo: 4587) today announced the nomination of the second targeted peptide radiopharmaceutical clinical development candidate arising from their strategic partnership with RayzeBio, Inc., (“RayzeBio”), a privately held California-based targeted radiopharmaceutical company developing innovative cancer drugs. The development … [Read more…]
NOV03 Consistently Met Primary Endpoints for Signs and Symptoms of Dry Eye Disease Associated with Meibomian Gland Dysfunction NOV03 PDUFA Action Date is June 28, 2023 VAUGHAN, Ontario & HEIDELBERG, Germany–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated to helping people see better to live better, … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–$SAGE #Sage–Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Stifel 2023 CNS Days on Wednesday, March 29, 2023, at 11:00 a.m. ET. A live webcast of the presentation can be accessed on the … [Read more…]
DUBLIN–(BUSINESS WIRE)–The “Devic’s Syndrome Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030” report has been added to ResearchAndMarkets.com’s offering. Devic’s syndrome (Neuromyelitis optica) treatment accounted for a market value of US$ 217.7 Mn in 2021 and projected to grow at a CAGR of … [Read more…]
Industry-Leading Results Position ALZ-801 to Potentially Become the First Oral Agent that Can Slow or Even Stop and Prevent Alzheimer’s Pathology in Patients and Healthy Individuals at Risk for the Disease Robust Disease-Modifying Effects Observed Through 52 Weeks of Treatment with ALZ-801 Tablet in APOE4 Carriers with Early Alzheimer’s Disease New Data Further Validate Alzheon … [Read more…]
